Suchergebnisse - "Schlenk, Richard F"

PubPharm (321)

1

Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA) : results of the safety run-in phase

enthalten in: Haematologica | 2024

von Heudobler, D. | Luke, F. | Hahn, J. | +14

2

Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive post-remission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia

enthalten in: Haematologica | 2024

von Jaramillo, S. | Krisam, J. | Le Cornet, L. | +17

3

Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases

enthalten in: Acta dermato-venereologica | 2024

von Lonsdorf, A. | Edelmann, D. | Albrecht, T. | +7

4

ZygosityPredictor

enthalten in: Bioinformatics advances | 2024

von Rheinnecker, M. | Fröhlich, M. | Rübsam, M. | +6

5

ZygosityPredictor

enthalten in: bioRxiv.org | 2024

von Rheinnecker, M. | Fröhlich, M. | Rübsam, M. | +6

6

Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)

enthalten in: Frontiers in oncology | 2024

von Jung, S. | Schlenk, R. | Hackenbruch, C. | +7

7

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

enthalten in: Haematologica | 2023

von Kayser, S. | Sartor, C. | Giglio, F. | +16

8

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

enthalten in: NPJ precision oncology | 2023

von Mock, A. | Teleanu, M. | Kreutzfeldt, S. | +29

9

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen

enthalten in: Clinical epigenetics | 2023

von Schmutz, M. | Zucknick, M. | Schlenk, R. | +8

10

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen

enthalten in: Clinical epigenetics | 2023

von Schmutz, M. | Zucknick, M. | Schlenk, R. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]